This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zumbansen, M.
Right arrow Articles by Stoffel, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zumbansen, M.
Right arrow Articles by Stoffel, W.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, June 2002, p. 3633-3638, Vol. 22, No. 11
0270-7306/02/$04.00+0     DOI: 10.1128/MCB.22.11.3633-3638.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Neutral Sphingomyelinase 1 Deficiency in the Mouse Causes No Lipid Storage Disease

Markus Zumbansen and Wilhelm Stoffel*

Laboratory of Molecular Neurosciences, Institute of Biochemistry, Faculty of Medicine, University of Cologne, Cologne, Germany

Received 26 November 2001/ Returned for modification 28 January 2002/ Accepted 26 February 2002

Sphingomyelin is a major lipid in the bilayer of subcellular membranes of eukaryotic cells. Different sphingomyelinases catalyze the initial step in the catabolism of sphingomyelin, the hydrolysis to phosphocholine and ceramide. Sphingomyelinases have been postulated to generate ceramide as a lipophilic second messenger in intracellular signaling pathways involved in cell proliferation, differentiation, or apoptosis. To elucidate the function of the first cloned Mg2+-dependent, neutral sphingomyelinase (nSMase 1) in sphingomyelin catabolism and its potential role in signaling processes in a genetic and molecular approach, we have generated an nSMase 1-null mutant mouse line by gene targeting. The nSMase 1-deficient mice show an unconspicuous phenotype and no accumulation or changed metabolism of sphingomyelin or other lipids, despite grossly reduced nSMase activity in all organs except brain. We also addressed the recent proposal that nSMase 1 possesses lysophospholipase C activity. The unaltered metabolism of lysophosphatidylcholine or lyso-platelet-activating factor excludes the proposed role of nSMase 1 as a lysophospholipase C.

* Corresponding author. Mailing address: Laboratory of Molecular Neurosciences, Institute of Biochemistry, Faculty of Medicine, University of Cologne, Joseph-Stelzmann-Straße 52, D-50931 Cologne, Germany. Phone: 49 (0)221-478-6881. Fax: 49 (0)221-478-6882. E-mail: wilhelm.stoffel{at}uni-koeln.de.

Molecular and Cellular Biology, June 2002, p. 3633-3638, Vol. 22, No. 11
0022-538X/02/$04.00+0     DOI: 10.1128/MCB.22.11.3633-3638.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Yabu, T., Shimuzu, A., Yamashita, M. (2009). A Novel Mitochondrial Sphingomyelinase in Zebrafish Cells. J. Biol. Chem. 284: 20349-20363 [Abstract] [Full Text]  
  • Pavoine, C., Pecker, F. (2009). Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology. Cardiovasc Res 82: 175-183 [Abstract] [Full Text]  
  • Yabu, T., Imamura, S., Yamashita, M., Okazaki, T. (2008). Identification of Mg2+-dependent Neutral Sphingomyelinase 1 as a Mediator of Heat Stress-induced Ceramide Generation and Apoptosis. J. Biol. Chem. 283: 29971-29982 [Abstract] [Full Text]  
  • Corcoran, C. A., He, Q., Ponnusamy, S., Ogretmen, B., Huang, Y., Sheikh, M. S. (2008). Neutral Sphingomyelinase-3 Is a DNA Damage and Nongenotoxic Stress-Regulated Gene That Is Deregulated in Human Malignancies. Mol Cancer Res 6: 795-807 [Abstract] [Full Text]  
  • Kim, W. J., Okimoto, R. A., Purton, L. E., Goodwin, M., Haserlat, S. M., Dayyani, F., Sweetser, D. A., McClatchey, A. I., Bernard, O. A., Look, A. T., Bell, D. W., Scadden, D. T., Haber, D. A. (2008). Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias. Blood 111: 4716-4722 [Abstract] [Full Text]  
  • Stoffel, W., Jenke, B., Holz, B., Binczek, E., Gunter, R. H., Knifka, J., Koebke, J., Niehoff, A. (2007). Neutral Sphingomyelinase (SMPD3) Deficiency Causes a Novel Form of Chondrodysplasia and Dwarfism That Is Rescued by Col2A1-Driven smpd3 Transgene Expression. Am. J. Pathol. 171: 153-161 [Abstract] [Full Text]  
  • Tani, M., Hannun, Y. A. (2007). Neutral Sphingomyelinase 2 Is Palmitoylated on Multiple Cysteine Residues: ROLE OF PALMITOYLATION IN SUBCELLULAR LOCALIZATION. J. Biol. Chem. 282: 10047-10056 [Abstract] [Full Text]  
  • Ng, C. G., Griffin, D. E. (2006). Acid Sphingomyelinase Deficiency Increases Susceptibility to Fatal Alphavirus Encephalomyelitis. J. Virol. 80: 10989-10999 [Abstract] [Full Text]  
  • Krut, O., Wiegmann, K., Kashkar, H., Yazdanpanah, B., Kronke, M. (2006). Novel Tumor Necrosis Factor-responsive Mammalian Neutral Sphingomyelinase-3 Is a C-tail-anchored Protein. J. Biol. Chem. 281: 13784-13793 [Abstract] [Full Text]  
  • Stoffel, W., Jenke, B., Block, B., Zumbansen, M., Koebke, J. (2005). Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and development. Proc. Natl. Acad. Sci. USA 102: 4554-4559 [Abstract] [Full Text]  
  • Marchesini, N., Luberto, C., Hannun, Y. A. (2003). Biochemical Properties of Mammalian Neutral Sphingomyelinase2 and Its Role in Sphingolipid Metabolism. J. Biol. Chem. 278: 13775-13783 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»